Lenz Therapeutics, Inc. Stock Forecast
Evaluation of Lenz Therapeutics, Inc. stock downgraded after the last trading session.
(Updated on Jun 20, 2024)
The Lenz Therapeutics, Inc. stock price fell by -1.42% on the last day (Thursday, 20th Jun 2024) from $18.32 to $18.06. It has now fallen 6 days in a row. During the last trading day the stock fluctuated 5.07% from a day low at $17.84 to a day high of $18.75. The price has fallen in 7 of the last 10 days but is still up by 11.97% over the past 2 weeks. Volume has increased on the last day by 15 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 237 thousand shares were bought and sold for approximately $4.28 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -13.12% during the next 3 months and, with a 90% probability hold a price between $12.30 and $17.04 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
LENZ Signals & Forecast
The Lenz Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $18.52. On a fall, the stock will find some support from the long-term average at approximately $16.62. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 11, 2024, and so far it has fallen -4.80%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Lenz Therapeutics, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $16.18 and $15.87. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Lenz Therapeutics, Inc. finds support just below today's level at $16.18. If this is broken, then the next support from accumulated volume will be at $15.87 and $15.72.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.91 between high and low, or 5.07%. For the last week, the stock has had daily average volatility of 6.11%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (LENZ) For The Upcoming Trading Day Of Friday 21st
For the upcoming trading day on Friday, 21st we expect Lenz Therapeutics, Inc. to open at $18.22, and during the day (based on 14 day Average True Range), to move between $16.79 and $19.33, which gives a possible trading interval of +/-$1.27 (+/-7.05%) up or down from last closing price. If Lenz Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.11% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $18.32 (1.44%) than the support at $16.18 (10.41%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Lenz Therapeutics, Inc. stock A Buy?
Lenz Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score: -1.343 Sell Candidate Downgraded
Predicted Opening Price for Lenz Therapeutics, Inc. of Friday, June 21, 2024
| Fair opening price June 21, 2024 | Current price |
|---|---|
| $18.22 ( 0.86%) | $18.06 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for LENZ
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 19.12 | 5.87% |
| R2 | 18.77 | 3.96% |
| R1 | 18.56 | 2.77% |
| Price | 18.06 | |
| S1 | 17.87 | -1.06% |
| S2 | 17.66 | -2.24% |
| S3 | 17.31 | -4.15% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 21.81 | 20.76% |
| R2 | 21.22 | 17.50% |
| R1 | 18.32 | 1.44% |
| Price | 18.06 | |
| S1 | 16.18 | -10.41% |
| S2 | 15.87 | -12.13% |
| S3 | 15.72 | -12.96% |
LENZ Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Mar 22, 2024 | Mar 22, 2024 | Mar 22, 2024 | $7.21 | 44.51% |
| 2 | Mar 15, 2024 | Mar 15, 2024 | Mar 15, 2024 | $7.21 | 45.60% |
FAQ
Click here for our free guide on how to buy Lenz Therapeutics, Inc. Stock.
